Skip to content

Oric Pharmaceuticals, Inc. ORIC Book value per share

Book value per share at other companies

Pfizer logo
PfizerPFE
$15.72-0.6%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$7.19+20.3%
CG Oncology logo
CG OncologyCGON
$12.92+39.6%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$4.67+4.1%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-$1.35-122%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$6.26+6.2%

Other financials

Income statement

See full
Operating income-$39.6M-21.1%
Net income-$35.8M-19.1%
EPS (diluted)-$0.34+19.0%

Balance sheet

See full
Cash & equivalents$56.4M+14.3%
Total debt$3.3M+2.6%
Total equity$415.6M+89.1%
Total assets$436.8M+79.8%

Cash flow

See full
Operating cash flow-$32.4M+0.3%
CapEx$2.0K-99.5%
Free cash flow-$32.4M+1.5%

Valuation

See full
Market cap$976.17M+23.0%
Enterprise value$923.07M+23.5%

Returns & leverage

See full
Return on equity-42.6%-4.6pp
Debt / equity0.0×
Current ratio16.3×+4.3×

Where this comes from

Calculated from Oric Pharmaceuticals, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oric Pharmaceuticals, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oric Pharmaceuticals, Inc.'s book value per share?
Oric Pharmaceuticals, Inc. (ORIC) reported book value per share of $3.94 in Q1 2026.
How has Oric Pharmaceuticals, Inc.'s book value per share changed year-over-year?
Oric Pharmaceuticals, Inc.'s book value per share increased by 27.4% year-over-year, from $3.09 to $3.94.
What is the long-term trend for Oric Pharmaceuticals, Inc.'s book value per share?
Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s book value per share has grown at a -19.8% compound annual growth rate (CAGR), from $13.21 to $4.38.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.